Medication Guide - 8/20/2021

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More Drug Name Active Ingredient Form;Route Appl. No. Company Date Opdivo Nivolumab INJECTABLE;INJECTION 125554 BRISTOL MYERS SQUIBB 08/19/2021 Campath Alemtuzumab VIAL; INTRAVENOUS 103948 GENZYME 08/18/2021 Jardiance Empagliflozin TABLET;ORAL 204629 BOEHRINGER INGELHEIM 08/18/2021 Lemtrada Alemtuzumab INJECTABLE;INJECTION 103948 GENZYME 08/18/2021 Entyvio Vedolizumab INJECTABLE;INJECTION 125476 TAKEDA PHARMS USA 08/17/2021 Jemperli Dostarlimab-Gxly INJECTABLE;INJECTION 761223 GLAXOSMITHKLINE LLC 08/17/2021 Aveed Testosterone Undecanoate INJECTABLE;INTRAMUSCULAR 022219 ENDO PHARMS INC 08/16/2021 Welireg Belzutifan TABLET;ORAL 215383 MERCK SHARP DOHME 08/13/2021 Xeomin Incobotulinumtoxina INJECTABLE;INJECTION 125360 MERZ PHARMS 08/13/2021 Xyrem Sodium Oxybate SOLUTION;ORAL 021196 JAZZ PHARMS 08/12/2021 Xywav Calcium Oxybate; Magnesium Oxybate; Potassium Oxybate; Sodium Oxybate SOLUTION;ORAL 212690 JAZZ 08/12/2021 Cellcept Mycophenolate Mofetil CAPSULE;ORAL 050722 ROCHE PALO 08/11/2021 Cellcept Mycophenolate Mofetil TABLET;ORAL 050723 ROCHE PALO 08/11/2021 Cellcept Mycophenolate Mofetil Hydrochloride INJECTABLE;INJECTION 050758 ROCHE PALO 08/11/2021 Cellcept Mycophenolate Mofetil SUSPENSION;ORAL 050759 ROCHE PALO 08/11/2021 Myfortic Mycophenolic Acid TABLET, DELAYED RELEASE;ORAL 050791 NOVARTIS 08/11/2021 Brilinta Ticagrelor TABLET;ORAL 022433 ASTRAZENECA 08/10/2021 Keytruda Pembrolizumab SOLUTION;INTRAVENOUS 125514 MERCK SHARP DOHME 08/10/2021 Lacosamide Lacosamide TABLET;ORAL 204857 AMNEAL PHARMS NY 08/10/2021 Rapamune Sirolimus TABLET;ORAL 021110 PF PRISM CV 08/09/2021 Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA